Up next

Autoplay

SPRINT Trial: NF1 With PNs

0 Views • 07/02/23
Share
Embed
administrator
administrator
Subscribers
0

A review of the phase 2 SPRINT study using selumetinib for the treatment of neurofibromatosis type 1 with plexiform neurofibromas.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay